MRSA Research - Methicillin-Resistant Staphylococcus Aureus, Hospitals, Infection, Antibiotic Resistance, Superbugs

MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.


MRSA Research Today

Home

View Latest Issue

Information About MRSA

Books on MRSA

Advertising in Research Today

View Other Research Today Publications



Volume 7 (2010), Issue 2 (February)

  1. Community-associated CMRSA-10 (USA-300) is the predominant strain among methicillin-resistant Staphylococcus aureus strains causing skin and soft tissue infections in patients presenting to the emergency department of a Canadian tertiary care hospital.
    J Emerg Med, 38(1): 6-11. [Abstract] [Full-text]
  2. Muscle-flap salvage of prosthetic dural repair.
    J Plast Reconstr Aesthet Surg, 63(2): 213-7. [Abstract] [Full-text]
  3. Methicillin-resistant Staphylococcus aureus and Staphylococcus pseudintermedius in veterinary medicine.
    Vet Microbiol, 140(3): 418-29. [Abstract] [Full-text]
  4. Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid.
    J Clin Microbiol, 48(2): 568-74. [Abstract] [Full-text]
  5. Daptomycin versus other antimicrobial agents for the treatment of skin and soft tissue infections: a meta-analysis.
    Ann Pharmacother, 44(1): 97-106. [Abstract] [Full-text]
  6. Development of a high cell-density protocol for the production of pregallidermin, a non-toxic precursor of the lantibiotic gallidermin.
    J Biotechnol, 145(2): 176-85. [Abstract] [Full-text]
  7. Staphylococcus aureus bacteremia in pediatric patients with cancer.
    Pediatr Infect Dis J, 29(2): 172-4. [Abstract] [Full-text]
  8. Proteomic approaches to study Staphylococcus aureus pathogenesis.
    J Proteomics, 73(4): 701-8. [Abstract] [Full-text]
  9. Use of automated repetitive-sequence-based PCR for rapid laboratory confirmation of nosocomial outbreaks.
    J Infect, 60(1): 44-51. [Abstract] [Full-text]
  10. Frequency of detection of methicillin-resistant Staphylococcus aureus from rectovaginal swabs in pregnant women.
    Am J Infect Control, 38(1): 72-4. [Abstract] [Full-text]
  11. Occurrence and genotyping using automated repetitive-sequence-based PCR of methicillin-resistant Staphylococcus aureus ST398 in Southeast Austria.
    Diagn Microbiol Infect Dis, 66(2): 217-21. [Abstract] [Full-text]
  12. Novel borate glass/chitosan composite as a delivery vehicle for teicoplanin in the treatment of chronic osteomyelitis.
    Acta Biomater, 6(3): 812-9. [Abstract] [Full-text]
  13. The epidemiology of methicillin-susceptible and methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit, 2000-2007.
    J Perinatol, 30(2): 135-9. [Abstract] [Full-text]
  14. Community-acquired methicillin-resistant Staphylococcus aureus in surgically treated hand infections.
    J Hand Surg Am, 35(1): 97-103. [Abstract] [Full-text]
  15. Identification of a new methicillin-resistant Staphylococcus aureus strain that cannot be assigned to any known spa type.
    J Clin Microbiol, 48(2): 626-7. [Abstract] [Full-text]
  16. Evaluation of risk factors for coinfection or cocolonization with vancomycin-resistant enterococcus and methicillin-resistant Staphylococcus aureus.
    J Clin Microbiol, 48(2): 628-30. [Abstract] [Full-text]
  17. Outbreak of skin infections in college football team members due to an unusual strain of community-acquired methicillin-susceptible Staphylococcus aureus.
    J Clin Microbiol, 48(2): 609-11. [Abstract] [Full-text]
  18. Carriage of community-associated methicillin-resistant Staphylococcus aureus in a cohort of infants in southern Israel: risk factors and molecular features.
    J Clin Microbiol, 48(2): 531-8. [Abstract] [Full-text]
  19. Genetic correlation of community-associated methicillin-resistant Staphylococcus aureus strains from carriers and from patients with clinical infection in one region of Korea.
    J Korean Med Sci, 25(2): 197-202. [Abstract] [Full-text]
  20. Methicillin-resistant Staphylococcus aureus infections may not impede the success of ultrasound-guided drainage of puerperal breast abscesses.
    J Am Coll Surg, 210(2): 148-54. [Abstract] [Full-text]
  21. Perioperative management of neurosurgical patients with methicillin-resistant Staphylococcus aureus.
    J Neurosurg, 112(2): 354-61. [Abstract] [Full-text]
  22. Antibacterial effect of essential oils from two medicinal plants against Methicillin-resistant Staphylococcus aureus (MRSA).
    Phytomedicine, 17(2): 142-5. [Abstract] [Full-text]
  23. Molecular characterization of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus isolates in Egypt.
    Microbiol Res, 165(2): 152-62. [Abstract] [Full-text]
  24. Prevalence of clinical meticillin-resistant Staphylococcus aureus (MRSA) with high-level mupirocin resistance in Shanghai and Wenzhou, China.
    Int J Antimicrob Agents, 35(2): 114-8. [Abstract] [Full-text]
  25. Solid-phase synthesis and antibiotic activities of cyclodecapeptides on the scaffold of naturally occurring Laterocidin.
    Bioorg Med Chem Lett, 20(1): 164-7. [Abstract] [Full-text]
  26. Novel neofusapyrones isolated from Verticillium dahliae as potent antifungal substances.
    Bioorg Med Chem Lett, 20(2): 709-12. [Abstract] [Full-text]
  27. Bactericidal activity of daptomycin versus vancomycin in the presence of human albumin against vancomycin-susceptible but tolerant methicillin-resistant Staphylococcus aureus (MRSA) with daptomycin minimum inhibitory concentrations of 1-2microg/mL.
    Int J Antimicrob Agents, 35(2): 131-7. [Abstract] [Full-text]
  28. Purification, characterisation and identification of acidocin LCHV, an antimicrobial peptide produced by Lactobacillus acidophilus n.v. Er 317/402 strain Narine.
    Int J Antimicrob Agents, 35(3): 255-60. [Abstract] [Full-text]
  29. The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii.
    Bioorg Med Chem, 18(2): 663-74. [Abstract] [Full-text]
  30. From green to red--To more dead? Autofluorescent proteins as photosensitizers.
    J Photochem Photobiol B, 98(1): 95-8. [Abstract] [Full-text]
  31. Synergistic effects between aminoethyl-chitosans and beta-lactams against methicillin-resistant Staphylococcus aureus (MRSA).
    Bioorg Med Chem Lett, 20(3): 975-8. [Abstract] [Full-text]
  32. Evaluation of the activity of fusidic acid tested against contemporary Gram-positive clinical isolates from the USA and Canada.
    Int J Antimicrob Agents, 35(3): 282-7. [Abstract] [Full-text]
  33. The role of polymethylmethacrylate antibiotic-loaded cement in addition to debridement for the treatment of soft tissue and osseous infections of the foot and ankle.
    J Foot Ankle Surg, 49(1): 55-62. [Abstract] [Full-text]
  34. An economic model for the prevention of MRSA infections after surgery: non-glycopeptide or glycopeptide antibiotic prophylaxis?
    Eur J Health Econ, 11(1): 57-66. [Abstract] [Full-text]
  35. Comparative genomics of epidemic versus sporadic Staphylococcus aureus strains does not reveal molecular markers for epidemicity.
    Infect Genet Evol, 10(1): 89-96. [Abstract] [Full-text]
  36. Genomic variation and evolution of Staphylococcus aureus.
    Int J Med Microbiol, 300(2): 98-103. [Abstract] [Full-text]
  37. Emergence of methicillin-resistant Staphylococcus aureus (MRSA) in different animal species.
    Int J Med Microbiol, 300(2): 109-17. [Abstract] [Full-text]
  38. Characterization of the in vitro activity of novel lipoglycopeptide antibiotics.
    Curr Protoc Microbiol. [Abstract] [Full-text]
  39. Severe rotational deformity, quadriparesis and respiratory embarrassment due to osteomyelitis at the occipito-atlantoaxial junction.
    J Bone Joint Surg Br, 92(2): 286-8. [Abstract] [Full-text]
  40. Nosocomial infections in neonatal intensive care units: profile, risk factor assessment and antibiogram.
    Indian J Pediatr, 77(1): 37-9. [Abstract] [Full-text]
  41. Antibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infection.
    Proc Natl Acad Sci U S A, 107(5): 2241-6. [Abstract] [Full-text]
  42. Junior doctors' knowledge and perceptions of antibiotic resistance and prescribing: a survey in France and Scotland.
    Clin Microbiol Infect. [Abstract] [Full-text]
  43. Increased prevalence of and associated mortality with methicillin-resistant Staphylococcus aureus among hospitalized IBD patients.
    Am J Gastroenterol, 105(2): 371-7. [Abstract] [Full-text]
  44. Susceptibility of Staphylococcus aureus strains toward combinations of oxacillin-2,4-dihydroxychalcone.
    Folia Microbiol (Praha), 54(6): 516-20. [Abstract] [Full-text]
  45. Qualitative Risk Assessment of the Acquisition of Meticillin-Resistant Staphylococcus aureus in Pet Dogs.
    Risk Anal. [Abstract] [Full-text]
  46. Lack of transmission of methicillin-resistant Staphylococcus aureus (MRSA) between apparently healthy dogs in a rescue kennel.
    Vet Microbiol, 141(1): 178-81. [Abstract] [Full-text]
  47. Methicillin-resistant Staphylococcus aureus in horses and horse personnel: an investigation of several outbreaks.
    Vet Microbiol, 141(1): 96-102. [Abstract] [Full-text]
  48. Vancomycin MIC creep in MRSA isolates from 1997 to 2008 in a healthcare region in Hong Kong.
    J Infect, 60(2): 140-5. [Abstract] [Full-text]
  49. Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms.
    Cancer, 116(4): 967-73. [Abstract] [Full-text]
  50. Decline of EMRSA-16 amongst methicillin-resistant Staphylococcus aureus causing bacteraemias in the UK between 2001 and 2007.
    J Antimicrob Chemother, 65(3): 446-8. [Abstract] [Full-text]
  51. Linezolid-resistant ST36 methicillin-resistant Staphylococcus aureus associated with prolonged linezolid treatment in two paediatric cystic fibrosis patients.
    J Antimicrob Chemother, 65(3): 442-5. [Abstract] [Full-text]
  52. Evaluation of linezolid, vancomycin, gentamicin and ciprofloxacin in a rabbit model of antibiotic-lock technique for Staphylococcus aureus catheter-related infection.
    J Antimicrob Chemother, 65(3): 525-30. [Abstract] [Full-text]
  53. Use of a Tunnelled Pleural Catheter for the Management of Refractory Hepatic Hydrothorax: A New Therapeutic Option.
    Respiration. [Abstract] [Full-text]
  54. PFGE diversity within the methicillin-resistant Staphylococcus aureus clonal lineage ST398.
    BMC Microbiol, 10(1): 40. [Abstract] [Full-text]
  55. Management of community-associated MRSA.
    Drug Ther Bull, 48(2): 14-9. [Abstract] [Full-text]
  56. Epidemiological typing of meticillin-resistant Staphylococcus aureus isolates from Pakistan and India.
    J Med Microbiol, 59: 330-7. [Abstract] [Full-text]
  57. Molecular characterization of methicillin-resistant Staphylococcus aureus isolates in Algeria.
    Pathol Biol (Paris). [Abstract] [Full-text]
  58. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
    Curr Med Res Opin, 26(3): 571-88. [Abstract] [Full-text]
  59. Chemical synthesis and biological screening of 2-aminoimidazole-based bacterial and fungal antibiofilm agents.
    Chembiochem, 11(3): 396-410. [Abstract] [Full-text]
  60. Chasing zero: our journey to preventing surgical site infection.
    AORN J, 91(2): 224-35. [Abstract] [Full-text]
  61. Potential therapeutic efficacy of a bactericidal-immunomodulatory fusion peptide against methicillin-resistant Staphylococcus aureus skin infection.
    Appl Microbiol Biotechnol, 86(1): 305-9. [Abstract] [Full-text]
  62. Taming the next-gen beast.
    Nat Rev Microbiol, 8(3): 161. [Abstract] [Full-text]
  63. The use of spa and phage typing for characterization of a MRSA population in a Belgian hospital: comparison between 2002 and 2007.
    Pathol Biol (Paris), 58(1): 70-2. [Abstract] [Full-text]
  64. Synthesis, characterization and antibacterial activities of some new ferrocene-containing penems.
    Eur J Med Chem, 45(3): 1181-8. [Abstract] [Full-text]
  65. Poor Functional Status Is an Independent Predictor of Surgical Site Infections Due to Methicillin-Resistant Staphylococcus aureus in Older Adults.
    J Am Geriatr Soc. [Abstract] [Full-text]
  66. Susceptibility to the main antibiotics of Escherichia coli and Staphylococcus aureus strains identified in community acquired infections in France (MedQual, 2004-2007).
    Med Mal Infect, 40(2): 74-80. [Abstract] [Full-text]
  67. Disseminated community-acquired USA300 methicillin-resistant Staphylococcus aureus pyomyositis and septic pulmonary emboli in an immunocompetent adult.
    Surg Infect (Larchmt), 11(1): 59-63. [Abstract] [Full-text]
  68. Risk factors for treatment failure in patients receiving vancomycin for hospital-acquired methicillin-resistant Staphylococcus aureus pneumonia.
    Surg Infect (Larchmt), 11(1): 21-8. [Abstract] [Full-text]
  69. The pathogen of ventilator-associated pneumonia does not influence the mortality rate of surgical intensive care unit patients treated with a rotational antibiotic system.
    Surg Infect (Larchmt), 11(1): 13-20. [Abstract] [Full-text]
  70. Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus.
    Clin Infect Dis, 50(6): 821-5. [Abstract] [Full-text]
  71. Molecular diversity within CC22 meticillin-resistant Staphylococcus aureus encoding Panton-Valentine Leukocidin in England and Wales.
    Clin Microbiol Infect. [Abstract] [Full-text]
  72. Nanoconjugated vancomycin: new opportunities for the development of anti-VRSA agents.
    Nanotechnology, 21(10): 105103. [Abstract] [Full-text]
  73. Impact of a change in antibiotic prophylaxis on total antibiotic use in a surgical intensive care unit.
    Infection, 38(1): 19-24. [Abstract] [Full-text]
  74. Comparative in vitro activities of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, and other quinolones against clinical isolates.
    Antimicrob Agents Chemother, 54(3): 1338-42. [Abstract] [Full-text]
  75. Longitudinal survey of Staphylococcus aureus in cystic fibrosis patients using a multiple-locus variable-number of tandem-repeats analysis method.
    BMC Microbiol, 10: 24. [Abstract] [Full-text]
  76. De novo sequencing of two new cyclic theta-defensins from baboon (Papio hamadryas) leukocytes by matrix-assisted laser desorption/ionization mass spectrometry.
    Rapid Commun Mass Spectrom, 24(5): 599-604. [Abstract] [Full-text]
  77. Contact precautions for multidrug-resistant organisms: Current recommendations and actual practice.
    Am J Infect Control, 38(2): 105-11. [Abstract] [Full-text]
  78. Surgical site infections: Causative pathogens and associated outcomes.
    Am J Infect Control, 38(2): 112-20. [Abstract] [Full-text]
  79. Patient segregation and aggressive antibiotic eradication therapy can control methicillin-resistant Staphylococcus aureus at large cystic fibrosis centres.
    J Cyst Fibros, 9(2): 104-9. [Abstract] [Full-text]
  80. International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009.
    Am J Infect Control, 38(2): 95-104.e2. [Abstract] [Full-text]
  81. ESBL, AmpC, and Carbapenemase Issues.
    J Clin Microbiol. [Abstract] [Full-text]
  82. Performance of fusidic acid (CEM-102) susceptibility testing reagents: broth microdilution, disk diffusion, and Etest methods as applied to Staphylococcus aureus.
    J Clin Microbiol, 48(3): 972-6. [Abstract] [Full-text]
  83. Emergence of SCCmec type IV and SCCmec type V methicillin-resistant Staphylococcus aureus containing the Panton-Valentine leukocidin genes in a large academic teaching hospital in central Switzerland: external invaders or persisting circulators?
    J Clin Microbiol, 48(3): 720-7. [Abstract] [Full-text]
  84. Clinical characteristics, outcomes, and microbiologic features associated with methicillin-resistant Staphylococcus aureus bacteremia in pediatric patients treated with vancomycin.
    J Clin Microbiol, 48(3): 894-9. [Abstract] [Full-text]
  85. Predominance and emergence of clones of hospital-acquired methicillin-resistant Staphylococcus aureus in Malaysia.
    J Clin Microbiol, 48(3): 867-72. [Abstract] [Full-text]
  86. To screen or not to screen for methicillin-resistant Staphylococcus aureus.
    J Clin Microbiol, 48(3): 683-9. [Abstract] [Full-text]
  87. Rapid detection of methicillin-resistant Staphylococcus aureus (MRSA) in diverse clinical specimens by the BD GeneOhm MRSA assay and comparison with culture.
    J Clin Microbiol, 48(3): 981-4. [Abstract] [Full-text]
  88. Automated detection of infectious disease outbreaks in hospitals: a retrospective cohort study.
    PLoS Med, 7(2): e1000238. [Abstract] [Full-text]
  89. Critical pneumonia complicating early-stage pregnancy.
    Anesth Analg, 110(3): 852-4. [Abstract] [Full-text]
Place a permanent text-link or advertisement here.

© 2004-2012 MRSA Research Today. All Rights Reserved.



MRSA Research Today Archive:

Volume 1 (2004)
  Issue 1 (October)
  Issue 2 (November)
  Issue 3 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 6 (2009)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 7 (2010)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 8 (2011)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 9 (2012)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)



MRSA Books

MRSA in Practice (In Practice Series)

MRSA in Practice (In Practice Series)